Please note that some translations using Google Translate may not be accurately represented, and image captions and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result for using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Burkitt lymphoma is a cancer of mature B-lymphocytes. It is a form of
non-Hodgkin lymphoma, which is a type of cancer that originates in cells of the immune system, called lymphocytes. Burkitt lymphoma is the most common type of non-Hodgkin lymphoma in children. It often grows first in the lymph tissue of the head and neck, including the tonsils, or in the abdomen. It grows rapidly, so symptoms often progress very quickly and children can become quite sick within a few days to weeks. Today, more than 90% of children with Burkitt lymphoma are cured of the disease.
Children with Burkitt lymphoma are treated at Dana-Farber/Boston Children's through our
Lymphoma Program. One of the top pediatric cancer centers worldwide, Dana-Farber/Boston Children’s combines the expertise of a premier cancer center — Dana-Farber Cancer Institute – and a world-class children’s hospital – Boston Children’s Hospital – to provide internationally-renowned care for children with cancers of the blood and immune system.
in-depth information on Burkitt Lymphoma on the Dana-Farber/Boston Children’s website, including Hodgkin lymphoma causes, diagnosis, treatment and latest research.
Appointments and Second Opinions